| Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark … M Ay, J Luo, M Langley, H Jin, V Anantharam, A Kanthasamy, ... Journal of neurochemistry 141 (5), 766-782, 2017 | 190 | 2017 |
| Mito-apocynin prevents mitochondrial dysfunction, microglial activation, oxidative damage, and progressive neurodegeneration in MitoPark transgenic mice M Langley, A Ghosh, A Charli, S Sarkar, M Ay, J Luo, J Zielonka, T Brenza, ... Antioxidants & redox signaling 27 (14), 1048-1066, 2017 | 126 | 2017 |
| Kv1. 3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease S Sarkar, HM Nguyen, E Malovic, J Luo, M Langley, BN Palanisamy, ... The Journal of clinical investigation 130 (8), 4195-4212, 2020 | 124 | 2020 |
| Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson’s disease: Relevance to gene and environment … MR Langley, S Ghaisas, M Ay, J Luo, BN Palanisamy, H Jin, ... Neurotoxicology 64, 240-255, 2018 | 61 | 2018 |
| Quercetin M Ay, A Charli, H Jin, V Anantharam, A Kanthasamy, AG Kanthasamy Nutraceuticals, 749-755, 2021 | 59 | 2021 |
| MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson’s disease S Ghaisas, MR Langley, BN Palanisamy, S Dutta, K Narayanaswamy, ... Neurotoxicology 75, 186-199, 2019 | 47 | 2019 |
| Protein kinase D1 (PKD1) phosphorylation promotes dopaminergic neuronal survival during 6-OHDA-induced oxidative stress A Asaithambi, M Ay, H Jin, A Gosh, V Anantharam, A Kanthasamy, ... PloS one 9 (5), e96947, 2014 | 38 | 2014 |
| Molecular cloning, epigenetic regulation, and functional characterization of Prkd1 gene promoter in dopaminergic cell culture models of Parkinson's disease M Ay, H Jin, DS Harischandra, A Asaithambi, A Kanthasamy, ... Journal of neurochemistry 135 (2), 402-415, 2015 | 28 | 2015 |
| Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease MR Langley, S Ghaisas, BN Palanisamy, M Ay, H Jin, V Anantharam, ... Experimental neurology 341, 113716, 2021 | 27 | 2021 |
| Neurotoxicity of vanadium HA Ngwa, M Ay, H Jin, V Anantharam, A Kanthasamy, AG Kanthasamy Neurotoxicity of Metals, 287-301, 2017 | 23 | 2017 |
| Vanillic acid induces mitochondrial biogenesis in SH-SY5Y cells M Ay Molecular Biology Reports 49 (6), 4443-4449, 2022 | 12 | 2022 |
| Mito-metformin protects against mitochondrial dysfunction and dopaminergic neuronal degeneration by activating upstream PKD1 signaling in cell culture and MitoPark animal … M Ay, A Charli, M Langley, A Jang, P Padhi, H Jin, V Anantharam, ... Frontiers in Neuroscience 18, 1356703, 2024 | 3 | 2024 |
| Evaluation of fisetin as a potential inducer of mitochondrial biogenesis in SH-SY5Y neuronal cells M Ay Iranian Journal of Basic Medical Sciences 26 (11), 1320, 2023 | 3 | 2023 |
| Translational drug discovery approaches targeting the PKD1 signaling in Parkinson's disease M Ay | 2 | 2016 |
| Rationally Designed PKD1 Activator Protects Against Neurodegeneration in Pre-clinical Models of Parkinson′ s Disease A Asaithambi, A Jang, A Ghosh, M Ay, H Jin, V Anantharam, ... bioRxiv, 2025 | | 2025 |
| Comparative Proteomics Highlights that GenX Exposure Leads to Metabolic Defects and Inflammation in Astrocytes A Abu-Salah, MF Cesur, A Anchan, M Ay, MR Langley, A Shah, ... Environmental Science & Technology 58 (46), 20525-20539, 2024 | | 2024 |
| Seminar: Functional Exposomics and Mechanisms of Toxicity—Insights from Model Systems and NAMs Y Lai, M Ay, CD Hospital, GW Miller, S Sarkar Environmental Health Perspectives 132 (9), 094201, 2024 | | 2024 |
| SRY GENİNİN PARKİNSON HASTALIĞINDAKİ POTANSİYEL ROLÜNÜN İN SİLİKO ANALİZİ M Ay Medical Journal of Süleyman Demirel University 30 (1), 19-24, 2023 | | 2023 |
| Mitochondrial Neurotoxic Pesticides Promote Epigenetic Dysregulation by Histone H3 and H4 Hyperacetylation in Dopaminergic Neuronal Model of Parkinson Disease A Charli, D Luo, M Langely, M Ay, H Jin, A Vellareddy, A Kanthasamy, ... INTERNATIONAL JOURNAL OF TOXICOLOGY 36 (1), 55-55, 2017 | | 2017 |
| Small molecule PKD1 activator protects progressive nigral dopaminergic neuronal degeneration in the MitoPark animal model of PD A Kanthasamy, M Ay, J Luo, M Langley, H Jin, V Anantharam, ... JOURNAL OF NEUROCHEMISTRY 134, 280-280, 2015 | | 2015 |
